← Back to news
Y

Yahoo Finance

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Y

FTSE 100 Live: London stocks outperform as pound falls on unemployment spike

Y

Gold Falls Below $5,000 in Thin Trade

Y

Walmart Earnings, GDP and Inflation Data: What to Watch This Week

Y

Nexo Returns to the US With New Offerings: What Changed Since Its 2022 Exit

Y

Down 35% Over the Past Year, Is Dutch Bros Stock a Buy as Same-Store Sales Growth Continues to Shine?

Y

Palantir vs. Nvidia: Wall Street Says This Is the Best AI Stock to Buy Now

Y

Nasdaq Futures Fell Monday Ahead of Busy Week

Y

Antofagasta Books Record Earnings, Driven by Higher Metal Prices

Y

Dollar Rises as Risk Aversion Boosts Safe Havens

Y

Global investors stay 'uber-bullish' but warn companies are overinvesting

Y

India's Adani to invest $100 billion in AI-ready data centres by 2035

Y

Australian Energy Major Wins Greenwashing Court Case

Y

Infosys reveals AI revenue share as sector faces growing disruption fears

Y

Stock market today: Dow, S&P 500, Nasdaq futures slide ahead of shortened week with AI fears in focus

Y

Stock market today: Dow, S&P 500, Nasdaq futures slide ahead of shortened week with AI disruption fears in focus

Y

Stock market today: Dow, S&P 500, Nasdaq futures fall ahead of shortened week with AI disruption fears in focus

Y

JPMorgan builds $2.93 billion stake in health care stock

Y

Has Chinese light vehicle demand peaked?

Y

Goldman Sachs sends harsh warning to U.S. credit card users

Y

Michael Burry made $100M by betting against the housing market in 2008, now he’s set his sights on AI with these moves

Y

BILL Stock Down 24%, Core Revenue Up 17%: Why a 14% Portfolio Bet Signals Conviction

Y

Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake

Y

3 Dirt Cheap Stocks to Buy With $1,000 Right Now

Y

Billionaire BlackRock CEO Larry Fink Says 'Almost No One Is Close' To Saving The Nearly $2.1M Americans Claim They Need For A Comfortable Retirement

Y

Trump Declares 'Largest Tax Refund Season Ever' In 2026: 'One Big Beautiful Bill' Secures Everything Needed Until 2030

Y

Vitalik Buterin: Hedging on Prediction Markets Could 'Replace Fiat Currency'

Y

Up 50% in One Year: Why a Fund Cut $5 Million in TriMas Stock but Held Onto a 3% Position

Y

Metaplanet Posts $605 Million Loss After Spending Billions on Bitcoin

Y

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's Turnaround Plans. Will Investors Regret Buying?

Y

Real Estate Rebound? The 3X Play for Investors Betting on a Commercial Property Pivot

Y

What Makes BioMarin (BMRN) so Attractive

Y

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Y

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

Y

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Y

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

Y

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Y

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Y

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Y

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Y

Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating

Y

Here is Why Beam Therapeutics (BEAM) Appears so Attractive

Y

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)

Y

Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)

Y

Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026

Y

Atacicept’s Potential Approval Drives Favorable Views on Vera Therapeutics (VERA)

Y

Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study

Y

Here is Why Apogee Therapeutics (APGE) Appears Attractive

Y

Timely Tips And Tools On How To Invest In Stocks In This Market

Y

Prediction: 2 Stocks That Will Be Worth More Than Amazon 3 Years From Now

Y